Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

CRVS
Corvus Pharmaceuticals, Inc.
stock NASDAQ

At Close
Jun 13, 2025 3:59:55 PM EDT
4.17USD-1.651%(-0.07)765,190
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jun 13, 2025 9:28:30 AM EDT
4.27USD+0.708%(+0.03)106,753
After-hours
Jun 13, 2025 4:00:30 PM EDT
4.19USD+0.263%(+0.01)1,268
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
322.72M
CEO
Richard Miller
Headquarters
Burlingame, California, USA
Industry
Biotechnology
Related
OMERXLV
CRVS Stats
Avg. Vol. 10 Day
915,778
Avg. Vol. 30 Day
1,261,194
Employees
55
Market Cap
322,724,752
Shares Out.
77,114,636
On/Off Exchange
51%/49%
6 Month Beta
1.07
1 Year Beta
1.21
2 Year Beta
1.38
3 Year Beta
1.14
52 Week Low
1.75
52 Week High
10.00
SMA50
3.58
SMA200
5.31
1 Week
+7.03%
1 Month
+15.61%
3 Month
-7.41%
6 Month
-43.29%
1 Year
+105.15%
2 Year
+24.93%
5 Year
+32.02%
Profile
corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.

CRVS Stock Summary

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) stock price today is $4.17, and today's volume is 765,190. CRVS is down -1.651% today. The 30 day average volume is 1,261,194. CRVS market cap is 322.72M with 77,114,636 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC